Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer.

Neil Desai,Michael R. Folkert,Andrew Leiker,Yulong Yan,Daniel N. Costa,Robert T. Dess,Daniel E. Spratt,Aurelie Garant,Raquibul Hannan,Robert Timmerman

Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer.

2020

Neil Desai
Michael R. Folkert
Andrew Leiker
Yulong Yan
Daniel N. Costa
Robert T. Dess
Daniel E. Spratt
Aurelie Garant
Raquibul Hannan
Robert Timmerman

TPS381Background: Radiotherapy (RT) associated sexual dysfunction occurs in half of men following treatment for localized prostate cancer. Proposed mechanisms include vascular injury of adjacent in...

Keywords:

SABR volatility model
Prostate cancer
Pathology
Neurovascular bundle
Sexual dysfunction
Radiation therapy
Ablative case
Radiology
Prostate
Medicine
Randomized controlled trial
Urology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations